Xiaojing Wei

12PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Gene expression (incl. microarray and other genome-wide approaches)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 05, 2026
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.

|Mar 30, 2026
Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after the BTK inhibitor era.

Yuting Yan, Weihao Chen, Ying Yu

|Mar 05, 2026
Proteogenomic features define subtypes of mantle cell lymphoma.

Yuting Yan, Weihao Chen, Xinzhou Ge

|Feb 11, 2026
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Hao Sun, Romanos Sklavenitis Pistofidis, Shirong Liu

|Mar 12, 2025
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.

Ying Yu, Yuxi Li, Rui Cui

|Oct 07, 2024
Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström Macroglobulinemia.

Yuting Yan, Ying Yu, Wenjie Xiong

Pageof 2

Frequent Collaborators

8 joint publications

Gang An

6 joint publications

Lugui Qiu

5 joint publications

Shuhua Yi

5 joint publications

Yan Xu